WHO IS FURTHEST ALONG?U.S. drugmaker Pfizer and German partner BioNTech are the vaccine trailblazers. They were the first in the world to release full late-stage trial data on Nov.
18 and Britain was the first to approve the shot for emergency use on Dec. 3, followed by Canada on Dec. 9.Advisers to the U.S.
Food and Drug Administration (FDA) endorsed its emergency use on Dec. 10, paving the way for the agency to authorize the vaccine in days.
The European Medicines Agency (EMA) is due to complete its review by Dec. 29 and India is accelerating its review.WHO WILL BE NEXT?U.S.